Related Experiment Video
Updated: Sep 30, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
COVID-19 vaccination: The road ahead
Daniel M Altmann1, Rosemary J Boyton2,3
1Department of Immunology and Inflammation, Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, London, UK.
First-generation SARS-CoV-2 vaccines control COVID-19, but future strategies require optimizing vaccine boosting and developing durable immunity against new variants, especially for children.
Area of Science:
- Immunology
- Vaccinology
- Virology
Background:
- First-generation SARS-CoV-2 vaccines have been crucial in managing the COVID-19 pandemic.
- Inequitable vaccine distribution remains a significant global health challenge.
- Future pandemic preparedness requires addressing challenges in vaccine boosting and variant protection.
Purpose of the Study:
- To evaluate future strategies for SARS-CoV-2 vaccination.
- To optimize the immunological rationale for vaccine boosting intervals and composition.
- To explore approaches for building a durable immune repertoire against emerging viral variants.
Main Methods:
- Comparative analysis of existing and proposed vaccination strategies.
- Review of immunological data on vaccine effectiveness and durability.
- Assessment of technological advancements in vaccine development.
Main Results:
- The landscape of vaccine technologies and producers is becoming increasingly diverse.
- Debate exists between frequent boosting with ancestral vaccines versus variant-specific or pan-coronavirus approaches.
- Consideration for pediatric vaccination strategies is essential.
Conclusions:
- Optimizing vaccine boosting and developing broad-spectrum immunity are critical for future pandemic control.
- A heterogeneous approach to vaccine technologies and strategies is anticipated.
- Further research is needed to determine the most effective long-term vaccination plans against SARS-CoV-2 and future coronaviruses.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Preclinical Development: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

